Keywords: Ranbaxy, First-quarter 2012 financial results, Daiichi Sankyo

Ranbaxy sales rocket 55%, net rises four-fold

Article | 11 May 2012

Print This

Ranbaxy Laboratories (AB: BO), India’s largest drugmaker, came in with a stompingly good set of financial results this ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in